Furthermore, SBC Medical has secured priority sales rights for NBD’s existing products in Japan and South Korea. The Company plans to offer these proven solutions to external medical institutions, establishing a high-margin business-to-business (B2B) revenue stream and accelerating its expansion into broader Asian markets alongside NBD.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.